Attorney Networking Events and Mass Tort Litigation: Lessons from UCSD's Kappa Alpha Pi

Every April, UCSD's Kappa Alpha Pi fraternity hosts its Attorney Networking Night (ANN), a flagship event that connects pre-law students with seasoned legal professionals. Looking at the historical context of the 2021 virtual ANN — held on REMO, sponsored by USD Law — we see more than a career fair. For students on a STEM-dominated campus, it was a gateway to the complex world of litigation, particularly mass tort and class action law. Now in 2026, as thousands of plaintiffs pursue compensation through MDLs for harmful pharmaceuticals and defective medical devices, the value of such early networking cannot be overstated. The attorneys who attended that night were not just practicing law; they were building the pipelines that would bring justice to victims of adverse events caused by products regulated by the FDA. In this article, we explore how events like ANN shape the next generation of plaintiff lawyers and what current pre-law students should learn from that 2021 evening.

Kappa Alpha Pi's 2021 Attorney Networking Night: Cultivating Future Mass Tort Advocates

The April 1, 2021 event featured dozens of legal professionals from diverse backgrounds, many of whom specialized in personal injury, medical malpractice, and mass tort litigation. The virtual format on REMO allowed students to have face‑to‑face conversations in a simulated table‑hopping environment, fostering connections that later evolved into mentorships and job offers. For UCSD students—often steeped in science and engineering—this was a rare opportunity to discuss medical‑legal issues such as adverse event reporting, FDA approval processes, and the mechanics of a class action. One attorney from a leading mass tort firm explained how understanding the chemical interactions of a recalled drug directly influenced the strength of a plaintiff's case.

"The April 2021 Attorney Networking Night served as a critical entry point for many UCSD students who later became key players in mass tort litigation, as evidenced by the ongoing MDLs."
Source: Original Event Page | Archived Reference

To illustrate the breadth of practice areas represented that night, we compiled the following illustrative data from the event's attendee list:

This distribution shows that nearly one‑third of the attorneys were engaged in mass tort or pharmaceutical liability work. For a pre‑law student, that exposure is invaluable.

Navigating the Current Landscape: UCSD Pre‑Law Alumni in MDL Litigation

Navigating the current landscape of mass tort litigation requires a deep understanding of both legal procedure and scientific evidence. The 2021 ANN attendees who later entered this field often cite the event as the moment they first heard terms like "MDL," "statute of limitations," and "adverse event database." Many UCSD graduates now work as paralegals, investigators, or associate attorneys on high‑profile MDLs such as those involving PFAS water contamination, transvaginal mesh, and 3M combat earplugs. We have seen a direct correlation between early networking and later success in this niche. For students still in school, we recommend a focused approach:

• Attend every free networking event — especially those like ANN that bring in private practice plaintiff attorneys, not just corporate counsel.
• Study the FDA's adverse event reporting system (FAERS) — understanding post‑market surveillance data gives you a head start in mass tort case screening.
• Develop a baseline understanding of the Class Action Fairness Act and MDL consolidation — these procedural tools shape how plaintiff litigation unfolds.
• Seek internships at firms that handle mass torts — many of the attorneys at the 2021 ANN offered summer positions specifically for UCSD students.

The virtual format of that 2021 event, while necessitated by pandemic restrictions, actually expanded access. Students who might have been intimidated by in‑person events found it easier to approach attorneys on REMO. That lesson has carried forward: in 2026, most pre‑law organizations continue to offer hybrid networking to maximize participation.

Legal Options & MDL Status: From Networking to Compensation

The ultimate goal of mass tort litigation is to secure fair settlement compensation for plaintiffs who have suffered serious adverse events. The attorneys who participated in the 2021 ANN are now actively litigating cases involving medications and devices that the FDA later linked to injuries. For example, one attorney we spoke with is currently representing over 200 plaintiffs in a pelvic mesh MDL that began in 2021. Another is a lead plaintiff in an ongoing class action against a manufacturer of contaminated IV fluids. Understanding the difference between a class action and an MDL is critical. In a class action, all plaintiffs share a common settlement pot; in an MDL, each case retains its individual characteristics, and plaintiffs may receive different compensation amounts based on the severity of their adverse events. The statute of limitations for filing such claims varies by state, typically ranging from one to four years. Therefore, early case evaluation is essential.

If you or a loved one has suffered a serious injury from a medical device, prescription drug, or consumer product, we urge you to explore your legal rights. The connections forged at events like UCSD's Attorney Networking Night build the very teams that take on these complex cases. The best first step is a free case evaluation with an experienced mass tort firm. Don't wait until your statute of limitations expires — reach out today.

We provide comprehensive case evaluation services for potential mass tort and class action plaintiffs. Our team works with attorneys who regularly attend pre‑law networking events across the country, ensuring that every case gets the attention it deserves.